Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for Acute PID
NCT01160640Phase 2Completed
- Start
- Nov 2010
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pelvic inflammatory disease (PID) comparing Ceftriaxone/Doxycycline/Placebo with Ceftriaxone/Doxycycline/Metronidazole (2 arms). Primary endpoint: Clearance of Anaerobic Organisms From the Endometrium at 30 days. Started Nov 2010; status: completed.
02
Drugs
metronidazole
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT01160640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160640.